Literature DB >> 17356010

Impaired insulin secretion in a mouse model of ataxia telangiectasia.

Philip D Miles1, Kai Treuner, Marc Latronica, Jerrold M Olefsky, Carrolee Barlow.   

Abstract

Ataxia telangiectasia (A-T) is an autosomal recessive disease caused by mutations in the A-T mutated (ATM) gene. The gene encodes a serine/threonine kinase with important roles in the cellular response to DNA damage, including the activation of cell cycle checkpoints and induction of apoptosis. Although these functions might explain the cancer predisposition of A-T patients, the molecular mechanisms leading to glucose intolerance and diabetes mellitus (DM) are unknown. We have investigated the pathogenesis of DM in a mouse model of A-T. Here we show that young Atm-deficient mice show normal fasting glucose levels and normal insulin sensitivity. However, oral glucose tolerance testing revealed delayed insulin secretion and resulting transient hyperglycemia. Aged Atm-/- mice show a pronounced increase in blood glucose levels and a decrease in insulin and C-peptide levels. Our findings support a role for ATM in metabolic function and point toward impaired insulin secretion as the primary cause of DM in A-T.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356010     DOI: 10.1152/ajpendo.00259.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  32 in total

1.  The role of ATM and DNA damage in neurons: upstream and downstream connections.

Authors:  Karl Herrup; Jiali Li; Jianmin Chen
Journal:  DNA Repair (Amst)       Date:  2013-05-13

Review 2.  Post-mitotic role of the cell cycle machinery.

Authors:  Karl Herrup
Journal:  Curr Opin Cell Biol       Date:  2013-09-18       Impact factor: 8.382

3.  A role for AMPK in increased insulin action after serum starvation.

Authors:  James Kain Ching; Pooja Rajguru; Nandhini Marupudi; Sankha Banerjee; Jonathan S Fisher
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

4.  Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.

Authors:  Anthony D D'Souza; Ian A Parish; Sharen E McKay; Susan M Kaech; Gerald S Shadel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.

Authors:  Yong Deuk Kim; Tiangang Li; Seung-Won Ahn; Don-Kyu Kim; Ji-Min Lee; Seung-Lark Hwang; Yong-Hoon Kim; Chul-Ho Lee; In-Kyu Lee; John Y L Chiang; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

6.  Ataxia telangiectasia mutated influences cytochrome c oxidase activity.

Authors:  Akshar Y Patel; Todd M McDonald; Larry D Spears; James Kain Ching; Jonathan S Fisher
Journal:  Biochem Biophys Res Commun       Date:  2011-01-23       Impact factor: 3.575

7.  p53 is required for chloroquine-induced atheroprotection but not insulin sensitization.

Authors:  Babak Razani; Chu Feng; Clay F Semenkovich
Journal:  J Lipid Res       Date:  2010-03-05       Impact factor: 5.922

8.  Role of ataxia telangiectasia mutated in insulin signalling of muscle-derived cell lines and mouse soleus.

Authors:  I Jeong; A Y Patel; Z Zhang; P B Patil; S T Nadella; S Nair; L Ralston; J K Hoormann; J S Fisher
Journal:  Acta Physiol (Oxf)       Date:  2009-12-10       Impact factor: 6.311

Review 9.  Heart failure and diabetes: role of ATM.

Authors:  Mary C Wingard; Chad R Frasier; Mahipal Singh; Krishna Singh
Journal:  Curr Opin Pharmacol       Date:  2020-08-01       Impact factor: 5.547

10.  Phenotypic categorization of genetic skin diseases reveals new relations between phenotypes, genes and pathways.

Authors:  Ruslan I Sadreyev; Jamison D Feramisco; Hensin Tsao; Nick V Grishin
Journal:  Bioinformatics       Date:  2009-09-10       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.